Thank you for Subscribing to Life Science Review Weekly Brief
Curebase is developing a new approach to the entire clinical trial process with a distinct DCT model that revolves around the patient's lifestyle, allowing for diverse studies with larger patient populations.
Fremont, CA: Amendola Communications, a nationally recognized, award-winning healthcare and technology public relations and marketing firm, has declared that Curebase, a company committed to democratizing access to clinical studies, has chosen the agency to launch a comprehensive media and communications program highlighting its innovative Decentralized Clinical Trial (DCT) software platform and work to make clinical trials not only more patient-centric but also faster and more cost-efficient. The decision was taken after an extensive review of other national agencies.
Curebase is developing a new approach to the entire clinical trial process with a distinct DCT model that revolves around the patient's lifestyle, allowing for diverse studies with larger patient populations. The Curebase platform enables sponsors, CROs, and physicians to conduct first-of-its-kind study designs in which patients participate both at home and in real-world settings using best-in-class software.
"We are excited to leverage Amendola, which brings a stealthy team, strategic healthcare IT expertise, and a long history of proven wins," stated Tom Lemberg, founder and CEO of Curebase. "We are proud to have helped many companies rapidly complete their clinical research, including those who achieved emergency use authorization during the pandemic. Our vision is to make clinical research an option for all patients, regardless of their care setting, and we are certain the Amendola team will be terrific partners in these efforts."
"We look forward to the opportunity to help bring Curebase's vision for a democratized clinical research industry to life," stated agency CEO Jodi Amendola. "They are a fast-rising powerhouse in the DCT space—developing innovative approaches for their clients and redefining how the world executes healthcare research. Curebase is building a future that includes better diversity, quicker enrollment, and improved patient satisfaction for all clinical trials."